2003 News Archive
12/19/2003
Adherex Announces Closing Of $21.5 Million Financing
12/16/2003
Adherex Announces New Private Placement Of $21 Million
12/10/2003
Adherex Announces Agreement To Acquire Non-Cancer Assets From Cadherin Biomedical
12/4/2003
Adherex Announces Private Placement Of $1.9 Million In Convertible Notes
11/28/2003
Adherex Reports First Quarter Results
10/2/2003
Adherex Issued New Us Patent For Vascular Targeting Agents
9/26/2003
Adherex Technologies Reports Year End Results
9/2/2003
Adherex Appoints Senior Harvard Physician To Chair Scientific And Clinical Advisory Committees
7/30/2003
Adherex Issued Additional Patent For The Prevention Of Cancer Metastasis
7/15/2003
Adherex Expands Patent Protection For Vascular Targeting Agents To Include Anti-Angiogenics
6/26/2003
Adherex Granted Patent For A New Method Of Killing Tumor Cells
6/24/2003
Adherex Closes Private Placement Investment Of $3.0 Million In Convertible Notes
6/11/2003
Adherex Issued New Patent Which Further Strengthens Anti-Cancer Portfolio
5/30/2003
Adherex Technologies Reports Third Quarter Results
5/13/2003
Adherex Signs Screening Agreement With National Cancer Institute
4/7/2003
Adherex Releases New Findings On Exherin™
2/28/2003
Adherex Technologies Reports Second Quarter Results
2/19/2003
New CEO Announced for Adherex
Home
About Us
Product Candidates
Preclinical Pipeline
Collaborations
Partnering
Press Releases
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Events
Publications & Patents
Careers
Contact Us
© 2009 Adherex Technologies Inc.
Site Map
|
Internet Disclaimer Statement
|
Printer Friendly Version
site by
webslingerz